Attached files

file filename
EX-10.11 - EX-10.11 - TREACE MEDICAL CONCEPTS, INC.d111748dex1011.htm
EX-10.13 - EX-10.13 - TREACE MEDICAL CONCEPTS, INC.d111748dex1013.htm
S-1/A - S-1/A - TREACE MEDICAL CONCEPTS, INC.d111748ds1a.htm
EX-10.7 - EX-10.7 - TREACE MEDICAL CONCEPTS, INC.d111748dex107.htm
EX-10.6 - EX-10.6 - TREACE MEDICAL CONCEPTS, INC.d111748dex106.htm
EX-10.3 - EX-10.3 - TREACE MEDICAL CONCEPTS, INC.d111748dex103.htm
EX-10.1 - EX-10.1 - TREACE MEDICAL CONCEPTS, INC.d111748dex101.htm
EX-5.1 - EX-5.1 - TREACE MEDICAL CONCEPTS, INC.d111748dex51.htm
EX-4.2 - EX-4.2 - TREACE MEDICAL CONCEPTS, INC.d111748dex42.htm
EX-3.4 - EX-3.4 - TREACE MEDICAL CONCEPTS, INC.d111748dex34.htm
EX-3.2 - EX-3.2 - TREACE MEDICAL CONCEPTS, INC.d111748dex32.htm
EX-3.1 - EX-3.1 - TREACE MEDICAL CONCEPTS, INC.d111748dex31.htm
EX-1.1 - EX-1.1 - TREACE MEDICAL CONCEPTS, INC.d111748dex11.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated April 16, 2021, with respect to the financial statements of Treace Medical Concepts, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.

/s/ GRANT THORNTON LLP

Jacksonville, Florida

April 16, 2021